Suscribirse

Glucose-induced islet hyperemia is mediated by nitric oxide - 11/09/11

Doi : 10.1016/S0002-9610(99)80066-X 
Stefan Moldovan, MD, Edward Livingston, MD, Ren Shang Zhang, MD, PhD, Robert Kleinman, MD, Paul Girth, MD, F. Charles Brunicardi, MD
 From the Departments of Surgery and Medicine, Veterans Affairs Medical Center-West Los Angeles and University of California, Los Angeles Medical Center, Los Angeles, California, USA 

*Requests for reprints should be addressed to F. Charles Brunicardi, MD, Department of Surgery, Baylor College of Medicine, One Baylor Plaza, Houston, Texas 77030.

Presented at the 36th Annual Meeting of the Society for Surgery of the Alimentary Tract, San Diego, California, May 14–17, 1995.

Abstract

Purpose

To determine whether hyperglycemia affects pancreatic islet microcirculation in vivo and whether nitric oxide is a mediator.

Methods

Islet blood flow was measured before and after infusion of glucose during in vivo microscopy of mouse pancreatic islet. The pancreas of male BALB/c mice was exteriorized and viewed under the microscope utilizing monochromatic transmitted light. The carotid artery and tail vein were cannulated and systemic blood pressure was monitored continuously. Under fluorescent light, a 0.02 mL bolus of 2% fluorescein isothyocyanate (FITC-albumin) was injected intra-arterially and the first pulse of FITC-albumin through an islet capillary was videorecorded. Following equilibration, either glucose or normal saline 300 mg/g of body weight was given Intravenously. Five minutes later, a second bolus was given and the second pulse was videorecorded. The study was repeated in the presence of Nω-ni-tro-l-arginine methyl ester (l-NAME). The FITC-albumin bolus mean transit time (TT) and observed cross time (OCT) through the islet were calculated using slow-motion video analysis of the recorded images.

Results

Infusion of glucose resulted in a significant increase in islet blood flow with no change in systemic blood pressure: baseline TT was 20 ±1.3 pixel/0.03 sec and baseline OCT was 0.6 ±0.04 seconds; during hyperglycemia, TT was 16.1 ± 1 pixel/0.03 sec, and OCT was 0.48 ± 0.03 seconds (n = 11, P <0.05 versus basal via paired t-test). Continuous infusion of l-NAME negated the effect of hyperglycemia on islet blood flow: baseline TT was 20 ± 1.8 pixel/0.03 sec and OCT was and 0.6 ± 0.05 seconds; during hyperglycemia, TT was 20 ± 1.1 pixel/0.03 sec and OCT was 0.6 ±0.33 seconds (n = 10; P <0.05 versus glucose via unpaired t-test).

Conclusions

These data suggest that hyperglycemia results in Increased islet capillary flow and nitric oxide is a regulator of islet blood flow during in vivo microscopy of the mouse islet.

El texto completo de este artículo está disponible en PDF.

** This study was supported by NIH Grant 1R29DK 46441-01.


© 1996  Publicado por Elsevier Masson SAS.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 171 - N° 1

P. 16-20 - janvier 1996 Regresar al número
Artículo precedente Artículo precedente
  • Contributions of molecular genetics to the clinical management of colorectal cancer
  • Hartley S. Stem
| Artículo siguiente Artículo siguiente
  • Positron emission tomography to stage suspected metastatic colorectal carcinoma to the liver
  • João V. Vitola, Dominique Delbeke, Martin P. Sandler, Michelle G. Campbell, Thomas A. Powers, J. Kelly Wright, William C. Chapman, C. Wright Pinson

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.

¿Ya suscrito a @@106933@@ revista ?

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2025 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.